Fig. 2: Summary of SVR rates observed across LEGA-C—funded studies on each continent. | npj Gut and Liver

Fig. 2: Summary of SVR rates observed across LEGA-C—funded studies on each continent.

From: Closing the gap in HCV care: strategic collaboration between industry, academic, community, and nonprofit researchers

Fig. 2: Summary of SVR rates observed across LEGA-C—funded studies on each continent.

Data are shown as the total number of participants monitored for SVR and median (Q1, Q3) SVR12 or SVR across all projects per continent. The time point at which SVR is reported varies by project, with some studies using SVR12 as the primary endpoint, while others report SVR24 or SVR. aSVR data not reported. LEGA-C local elimination programs leading to global action in HCV, MINMON minimal monitoring, Q quartile, SVR sustained virologic response, SVR12 SVR at posttreatment week 12, SVR24 SVR at posttreatment week 24.

Back to article page